Your cells for your treatment: with its family of new generation therapies for hard & soft tissue reconstruction from autologous adipose stem cells
Novadip Biosciences offers a 3D solution without use of scaffold, for better clinical outcomes.
An innovative family of cell-based regeneration therapies. Novadip Biosciences pioneers the growth of 3-dimensional biologics based on adipose-derived stem cells (ASC), to regenerate hard and soft tissues. ASCs offer sizable advantages in regeneration medicine. The fatty tissue has demonstrated a much higher proportion of stem cells compared to the bone marrow, which is another reservoirRead More
Since 2013, Novadip Biosciences has been developing breakthrough innovations in cell-based therapies for hard and soft tissue. While our first mission was to treat patients with bone defects and bone diseases, our adipose stem cell-based technology now offers potential for further applications, including skin regeneration.Read More
Novadip Biosciences: a family of new generation, 3D therapies based on adipose stem cells, for hard and soft tissue reconstruction. Market application for NVD-001: bone healing disorders and critical size bone defects with unmet medical needs. Bone healing disorders and critical size bone defects following degenerative conditions, trauma, infection, congenital deficiency or tumour resectionRead More
Mont-Saint-Guibert, Belgium – May 30, 2017 – Advanced biopharmaceutical company NOVADIP BIOSCIENCES, which pioneers the growth of 3-dimensional tissues derived from aRead More
Please find job descriptions here.Read More